الفهرس | Only 14 pages are availabe for public view |
Abstract Adding second stage automated auditory brainstem response (AABR) test for infants who failed the initial OAE test has been shown to reduce false referrals to the hearing clinic. Infants with hearing loss may be missed by a 2-stage hearing screening although they pass the automated ABR test. In this systematic review, we offered a balanced document with the best evidence on efficiency of AABR for neonatal hearing loss screening. The use of sensitive and specific hearing screening measures is key for a successful and efficacious newborn hearing screening (NHS) program. Evidence suggests that a variety of objective screening measures, such as otoacoustic emissions (OAEs) or automated auditory brainstem response may be employed within such a program, their use is stated to be possible either in isolation or in combination with each other. Application of inclusion and exclusion criteria to study abstracts yielded 16 articles. A total of 280 studies were identified from the database search. After review, a total of 16 studies consisting of 462917 neonates undergoing screening of hearing loss by automated audiometry brain stem response. The inclusion criteria of the neonates included in the studies such as neonates with Median income of 72% or less, who remained in the NICU for at least 48 hours, have at least 37 weeks gestational age at birth, have more than 24 hours of life, or Healthy newborns without a history of NICU hospitalization born. Most of the studies referred the cases with failure to pass automated auditory brainstem response test to confirmatory diagnostic testing with auditory brainstem response for further rehabilitation (hearing aids or cochlear implant) and speech rehabilitation process |